Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
NBTX
NBTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NBTX News
Palvella Therapeutics Stock Soars to $114.69 Following Pipeline Developments
Dec 31 2025
NASDAQ.COM
Nanobiotix Reports Voting Rights and Share Capital Data
Dec 17 2025
Globenewswire
Shareholder Voting Rights and Company Capital Structure
Dec 17 2025
Yahoo Finance
Nanobiotix Joins CAC Mid 60 and SBF 120 Indices, Enhancing Market Visibility
Dec 15 2025
Globenewswire
Nanobiotix Joins CAC Mid 60 and SBF 120 Indices, Enhancing Market Visibility
Dec 15 2025
Newsfilter
Semtech Reports Mixed Q3 Results, Alongside Zhihu, Nvidia, and Other Major Stocks Declining in Tuesday's Pre-Market Trading
Nov 25 2025
Benzinga
Keysight Shares Rise Approximately 15%; Check Out 20 Stocks Making Moves in Premarket Trading
Nov 25 2025
Benzinga
Nanobiotix Closes $71 Million Royalty Financing with HCRx
Nov 24 2025
Newsfilter
NANOBIOTIX to Attend Jefferies London Healthcare Conference
Nov 11 2025
Yahoo Finance
Outset Medical, Gemini Space Station, CoreWeave, and Other Major Stocks Decline in Tuesday's Pre-Market Trading
Nov 11 2025
Benzinga
NANOBIOTIX to Attend Investor Conferences During the Week of November 10th
Nov 03 2025
Newsfilter
Major Stocks Including Wayfair, Qorvo, Celestica, UPS, and Regeneron Pharmaceuticals Rise on Tuesday
Oct 28 2025
Benzinga
Carter's, Newmont Corporation, and Other Major Stocks Decline in Monday's Pre-Market Trading
Oct 27 2025
Benzinga
Avidity Biosciences Stock Rises Approximately 42%; Check Out 20 Stocks Making Moves in Premarket Trading
Oct 27 2025
Benzinga
Nanobiotix Sees Gains Following Initial Trial Results for Cancer Drug Developed in Partnership with J&J
Oct 02 2025
SeekingAlpha
NANOBIOTIX Reveals Initial Findings from Phase 1 Trial of JNJ-1900 (NBTXR3) in Esophageal Cancer Patients
Oct 01 2025
Newsfilter
Show More News
